METASTATIC KIDNEY MEDULLARY CARCINOMA
Clinical trials for METASTATIC KIDNEY MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC KIDNEY MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC KIDNEY MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Rare cancer hope: immune drug shows promise in phase 2 trial
Disease control OngoingThis study tested a drug called pembrolizumab in 157 people with rare cancers that had spread or couldn't be removed. The drug works by helping the body's immune system attack the cancer. The main goal was to see how many patients were alive and their cancer hadn't grown after 27…
Matched conditions: METASTATIC KIDNEY MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug cocktail targets rare, aggressive kidney cancer
Disease control OngoingThis phase II trial is testing whether combining the targeted drug ixazomib with two chemotherapy drugs (gemcitabine and doxorubicin) can shrink tumors or stop them from growing in patients with a rare and aggressive kidney cancer called renal medullary carcinoma. The study enrol…
Matched conditions: METASTATIC KIDNEY MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC